Anifrolumab is under clinical development by AstraZeneca and currently in Phase II for Vitiligo. According to GlobalData, Phase II drugs for Vitiligo have a 42% phase transition success rate (PTSR) ...

Amivantamab is under clinical development by Johnson & Johnson and currently in Phase I for Gastroesophageal (GE) Junction Carcinomas.

Activator of G-protein signaling C-terminus serves as a variable element to induce asymmetric cell division, facilitating developmental diversity among species.

Techopedia looks at rumors and leaks surrounding the AMD RDNA 4, including the expected release date, features, and pricing.

The video is quite technical and begins with Cerny outlining what Sony is hoping to achieve with the PS5 Pro. He says that ...

Sony has officially blown the lid off of the PlayStation 5 Pro's internal hardware and new PSSR upscaling tech, revealing key details on AI, ML, and more.

Despite being positive about DNA-based vaccine production in general, the study did identify areas in need of better ...

In fact, in his latest deep dive into the tech behind PS5 Pro, Cerny revealed that Sony and AMD are entering into a strategic partnership, called Project Amethyst, with the goal of developing and ...

Digital Foundry breaks down the hardware and software of the PS5 Pro, including its GPU, RT improvements, PSSR and machine learning features, and next-gen.

We sit down with PS5 architect Mark Cerny to discuss PSSR, the future of game graphics, and what Sony's partnership with AMD ...

Novo Nordisk made a submission to the U.S. Food and Drug Administration (FDA) nominating Novo Nordisk’s semaglutide ...